Why don't we ever hear about Post-Dutasteride Syndrome?
Linked videos:
• What to do if you get side effects fr...
• Vioxx and finasteride, how frivolous ...
• Why dutasteride stops hair loss forever
Sources:
1. Zhou Z, Cui Y, Wu J, Jin H. Efficacy and safety of dutasteride compared with finasteride in treating males with benign prostatic hyperplasia: A meta‑analysis of randomized controlled trials. Experimental and Therapeutic Medicine. 2020;20(2):1566-1574. doi:10.3892/etm.2020.8851
2. Lephart ED. Age-related changes in brain and pituitary 5 alpha-reductase with finasteride (Proscar) treatment. Neurobiol Aging. 1995;16(4):647-650. doi:10.1016/0197-4580(95)98115-5
3. Drake L, Hordinsky M, Fiedler V, et al. The effects of finasteride on scalp skin and serum androgen levels in men with androgenetic alopecia. J Am Acad Dermatol. 1999;41(4):550-554.
4. Stoffel-Wagner B. Neurosteroid metabolism in the human brain. European Journal of Endocrinology. 2001;145(6):669-679. doi:10.1530/eje.0.1450669
5. Clark RV, Hermann DJ, Cunningham GR, Wilson TH, Morrill BB, Hobbs S. Marked Suppression of Dihydrotestosterone in Men with Benign Prostatic Hyperplasia by Dutasteride, a Dual 5α-Reductase Inhibitor. The Journal of Clinical Endocrinology & Metabolism. 2004;89(5):2179-2184. doi:10.1210/jc.2003-030330
6. Olsen EA, Hordinsky M, Whiting D, et al. The importance of dual 5α-reductase inhibition in the treatment of male pattern hair loss: Results of a randomized placebo-controlled study of dutasteride versus finasteride. Journal of the American Academy of Dermatology. 2006;55(6):1014-1023. doi:10.1016/j.jaad.2006.05.007
7. Mondaini N, Gontero P, Giubilei G, et al. Finasteride 5mg and Sexual Side Effects: How Many of these are Related to a Nocebo Phenomenon? The Journal of Sexual Medicine. 2007;4(6):1708-1712. doi:10.1111/j.1743-6109.2007.00563.x
8. Traish AM. 5α-Reductases In Human Physiology: an Unfolding Story. Endocrine Practice. 2012;18(6):965-975. doi:10.4158/EP12108.RA
9. Boersma IH, Oranje AP, Grimalt R, Iorizzo M, Piraccini BM, Verdonschot EH. The effectiveness of finasteride and dutasteride used for 3 years in women with androgenetic alopecia. IJDVL. 2014;80:521. doi:10.4103/0378-6323.144162
10. Jung JY, Yeon JH, Choi JW, et al. Effect of dutasteride 0.5 mg/d in men with androgenetic alopecia recalcitrant to finasteride. Int J Dermatology. 2014;53(11):1351-1357. doi:10.1111/ijd.12060
11. Martinez PE, Rubinow DR, Nieman LK, et al. 5α-Reductase Inhibition Prevents the Luteal Phase Increase in Plasma Allopregnanolone Levels and Mitigates Symptoms in Women with Premenstrual Dysphoric Disorder. Neuropsychopharmacology. 2016;41(4):1093-1102. doi:10.1038/npp.2015.246
12. Shanshanwal SJS, Dhurat RS. Superiority of dutasteride over finasteride in hair regrowth and reversal of miniaturization in men with androgenetic alopecia: A randomized controlled open-label, evaluator-blinded study. IJDVL. 2017;83:47. doi:10.4103/0378-6323.188652
13. Swerdloff RS, Dudley RE, Page ST, Wang C, Salameh WA. Dihydrotestosterone: Biochemistry, Physiology, and Clinical Implications of Elevated Blood Levels. Endocr Rev. 2017;38(3):220-254. doi:10.1210/er.2016-1067
14. Andy G, John M, Mirna S, et al. Controversies in the treatment of androgenetic alopecia: The history of finasteride. Dermatologic Therapy. 2019;32(2):e12647. doi:10.1111/dth.12647
15. Choi GS, Sim WY, Kang H, et al. Long-Term Effectiveness and Safety of Dutasteride versus Finasteride in Patients with Male Androgenic Alopecia in South Korea: A Multicentre Chart Review Study. Ann Dermatol. 2022;34(5):349-359. doi:10.5021/ad.22.027
16. Escamilla-Cruz M, Magaña M, Escandón-Perez S, Bello-Chavolla OY. Use of 5-Alpha Reductase Inhibitors in Dermatology: A Narrative Review. Dermatol Ther (Heidelb). 2023;13(8):1721-1731. doi:10.1007/s13555-023-00974-4
17. Laanani M, Weill A, Jollant F, Zureik M, Dray-Spira R. Suicidal risk associated with finasteride versus dutasteride among men treated for benign prostatic hyperplasia: nationwide cohort study. Sci Rep. 2023;13(1):5308. doi:10.1038/s41598-023-32356-3
18. Wu D, Chen Q, Chen X, Han F, Chen Z, Wang Y. The blood–brain barrier: structure, regulation, and drug delivery. Sig Transduct Target Ther. 2023;8(1):1-27. doi:10.1038/s41392-023-01481-w
19. Almudaimeegh A, AlMutairi H, AlTassan F, AlQuraishi Y, Nagshabandi KN. Comparison between dutasteride and finasteride in hair regrowth and reversal of miniaturization in male and female androgenetic alopecia: a systematic review. Dermatol Reports. Published online April 12, 2024. doi:10.4081/dr.2024.9909
Watch video Why don't we ever hear about Post-Dutasteride Syndrome? online without registration, duration hours minute second in high quality. This video was added by user Haircafe 26 June 2024, don't forget to share it with your friends and acquaintances, it has been viewed on our site 19,06 once and liked it 74 people.